APA (7th ed.) Citation

Rezaeian, A., Phan, L. M., Zhou, X., Wei, W., & Inuzuka, H. (2023, April). Pharmacological inhibition of the SKP2/p300 signaling axis restricts castration-resistant prostate cancer. Neoplasia: An International Journal for Oncology Research.

Chicago Style (17th ed.) Citation

Rezaeian, Abdol-Hossein, Liem Minh Phan, Xiaobo Zhou, Wenyi Wei, and Hiroyuki Inuzuka. "Pharmacological Inhibition of the SKP2/p300 Signaling Axis Restricts Castration-resistant Prostate Cancer." Neoplasia: An International Journal for Oncology Research Apr. 2023.

MLA (9th ed.) Citation

Rezaeian, Abdol-Hossein, et al. "Pharmacological Inhibition of the SKP2/p300 Signaling Axis Restricts Castration-resistant Prostate Cancer." Neoplasia: An International Journal for Oncology Research, Apr. 2023.